1. News
  2. Sector

  3. Pharma & Healthcare

Lupin advances on launching generic Exforge in US

India Infoline News Service | Mumbai | April 01, 2015 14:03 IST

The stock is now trading with a gain of 1.9 per cent on the BSE.

Dr Reddys to acquire UCB India biz

India Infoline News Service | Mumbai | April 01, 2015 14:01 IST

The transaction includes approximately 350 employees engaged in the operation of the India business.

Dr.Reddy's surges on UCB deal

India Infoline News Service | Mumbai | April 01, 2015 13:52 IST

According to a release issued by the company to the BSE, Dr.Reddy's is set to acquire select portfolio of the established products business of UCB in India, Nepal, Sri Lanka and Maldives for Rs. 800 crore.

Lupin launches generic Exforge tablets In US

India Infoline News Service | Mumbai | April 01, 2015 13:48 IST

Lupin had received final approval from the United States Food and Drug Administration (FDA) for the product yesterday.

Pharmaceutical Newsletter - March 30 to April 01, 2015

India Infoline News Service | Mumbai | April 01, 2015 13:02 IST

Biotechnology firm Biocon Ltd is planning to file a prospectus for share listing for its research services business arm Syngene International within the next two months, according to reports.

Sun Pharma, Ranbaxy jump ahead of merger

India Infoline News Service | Mumbai | April 01, 2015 12:56 IST

Ranbaxy informed the BSE that committee of the directors of the company fixed 7, April 2015 as the record date to determine the names of the shareholders of Ranbaxy.

Dr. Reddys Lab stock up 1.5%

India Infoline News Service | Mumbai | April 01, 2015 12:30 IST

The pharma company to acquire select portfolio of the established products business of UCB in India.

Hindustan Wellness introduces a Master Wellness Package

India Infoline News Service | Mumbai | April 01, 2015 08:26 IST

The Master Wellness Package by Hindustan Wellness is a preventive health plan offering customers a gamut of benefits to keep them healthy all-round the year.

Syngene International appoints Peter Bains as CEO

India Infoline News Service | Mumbai | April 01, 2015 08:22 IST

Biocon Ltd has announced that the Company's Subsidiary M/s. Syngene International Limited (Syngene) has appointed Peter Bains, Director as the CEO of Syngene.

Being Human Clothing celebrates World Health Day with Celebrity Nutritionist Rujuta Diwekar

India Infoline News Service | Mumbai | April 01, 2015 08:21 IST

Rujuta Diwekar is amongst the most qualified and sought after Sports Science and Nutrition Expert in the country who has worked with clients from all walks of life, from businessmen to homemakers and celebrities.

Biocon plans to file for Syngene Intl IPO: Reports

India Infoline News Service | Mumbai | March 31, 2015 17:53 IST

A report said that IPO may fetch up to Rs 10 bn ($159.8 million).

Cipla gains on block deal

India Infoline News Service | Mumbai | March 31, 2015 10:11 IST

4 lakh equity shares have changed hands at the Cipla counter in a block deal at Rs 706.50 on the NSE.

OXXY and UBER tie up to provide Rs. 1,000 crore health benefits to Delhi

India Infoline News Service | Mumbai | March 31, 2015 10:06 IST

Any one travelling to any medical center i.e. Hospital, Diagnostic or Path Lab will get free rides driven by UBER.

Teva to buy U.S. drug developer Auspex Pharma

India Infoline News Service | Mumbai | March 30, 2015 18:38 IST

This transaction is expected to enhance Tevas revenue and earnings growth profile and strengthen its core central nervous system (CNS) franchise with the addition of Auspexs portfolio of innovative medicines for people who live with movement disorders.

Strides Arcolab stock closed 5% higher

India Infoline News Service | Mumbai | March 30, 2015 16:37 IST

The Company announced launch of the generic version of Hepatitis C drug 'Sofosbuvir' under the brand name 'Virso'.

Fortis Healthcare stock closed 2% up

India Infoline News Service | Mumbai | March 30, 2015 16:10 IST

The Board of Fortis Healthcare International Pte Ltd, a step down subsidiary of Fortis Healthcare Ltd (Fortis) based out of Singapore has decided to disinvest 100 % shareholding in Fortis Healthcare Singapore Pte Ltd.

Strides Arcolab zooms 5% on new drug launch

India Infoline News Service | Mumbai | March 30, 2015 13:49 IST

Strides Arcolab announced the launch of generic drug Sofosbuvir in India under the brand name 'Virso'.

FDI in pharma! Should there be restrictions?

India Infoline News Service | Mumbai | March 30, 2015 08:41 IST

The DIPP is working on a review of the FDI policy which will be placed before the Cabinet Committee on Economic Affairs after discussions with other govt departments.

Our objective is to integrate Ranbaxy at the earliest: Dilip Shanghvi

India Infoline News Service | Mumbai | March 29, 2015 21:47 IST

Shanghvi said that the primary objective of the company is to conclude Ranbaxy integration as early as possible so as to drive away attached uncertainties.

Back to Top

Reports
News